Use of D-Chiro-inositol in Male Functional Hypogonadism Associated With Sexual Dysfunction

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age50-75
SponsorCardarelli Hospital

About this trial

A prospective, uncontrolled, non-pharmacological interventional study conducted on men with functional or borderline hypogonadism, aimed at evaluating, after 3 months of supplementation with D-Chiro-inositol, changes in hormonal profile and sexual function.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Men aged between 50 and 75

Affected by functional hypogonadism associated with male aging

Disqualifiers

Elevated ferritin, PRL, and/or elevated CRP values; diagnosis of primary hypogonadism; diagnosis of organic hypogonadotropic hypogonadism or secondary to other ongoing acute or chronic pathologies; presence of other pituitary deficits.

Alcohol use and/or drug abuse, recent hormone treatment, smoking, systemic or endocrine diseases, infection of the male accessory glands, medical history of cryptorchidism or varicocele, and micro-orchidism.

Trial design

Design model

Single group

Treatments tested in this trial

  • D-chiro-inositol

    Dietary supplement

    Treatment with D-chiro-inositol (capsule) for 3 months 600 mg/2 die

Treatment groups

35 Participants
are divided into 1 treatment group
Group A: TreatedExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Testosterone levels

Variation of serum testosterone levels

Time frame
From enrollment to three months

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: